Cite This Page

Citation styles for Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy

APA style

Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy. (2024, January 25). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 14:39, May 12, 2024 from https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022.

MLA style

"Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 25 Jan 2024, 12:45 UTC. 12 May 2024, 14:39 <https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022>.

MHRA style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 25 January 2024, 12:45 UTC, <https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022> [accessed 12 May 2024]

Chicago style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022 (accessed May 12, 2024).

CBE/CSE style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 25, 12:45 UTC [cited 2024 May 12]. Available from: https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022.

Bluebook style

Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy, https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022 (last visited May 12, 2024).

BibTeX entry

 @misc{ wiki:xxx,
   author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
   title = "Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
   year = "2024",
   url = "https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022",
   note = "[Online; accessed 12-May-2024]"
 }

When using the LaTeX package url (\usepackage{url} somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:

 @misc{ wiki:xxx,
   author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
   title = "Design regarding disease along with a reaction to pembrolizumab inside recurrent cervical cancer malignancy --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
   year = "2024",
   url = "\url{https://news.npo.digital/index.php?title=Design_regarding_disease_along_with_a_reaction_to_pembrolizumab_inside_recurrent_cervical_cancer_malignancy&oldid=616022}",
   note = "[Online; accessed 12-May-2024]"
 }